Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018

Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018

Abstract Background Invasive pneumococcal disease (IPD) is a major cause of pediatric morbidity and mortality. Pneumococcal conjugate vaccines (PCVs) were introduced in the US in 2000 (PCV7) and 2010 (PCV13). This study estimated the annual incidence rates (IRs) and time trends of IPD to quantify th...

Full description

Bibliographic Details
Main Authors: Tianyan Hu, Yan Song, Nicolae Done, Qing Liu, Eric M. Sarpong, Esteban Lemus-Wirtz, James Signorovitch, Salini Mohanty, Thomas Weiss
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Public Health
Subjects:
Incidence rate estimates
Invasive pneumococcal disease
Pneumococcal conjugate vaccines
Online Access:https://doi.org/10.1186/s12889-022-14051-6

Internet

https://doi.org/10.1186/s12889-022-14051-6

Similar Items